cetylpyridinium chloride anhydrous has been researched along with Hashimoto Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barresi, G; Benvenga, S; Cardelli, P; Galletti, M; Ruggeri, RM; Sciacchitano, S; Trimarchi, F; Trovato, M; Vitale, A; Vitarelli, E | 1 |
| Banga, JP; Brix, TH; Gardas, A; Hegedüs, L; Nielsen, CH | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Hashimoto Disease
| Article | Year |
|---|---|
Serum hepatocyte growth factor is increased in Hashimoto's thyroiditis whether or not it is associated with nodular goiter as compared with healthy non-goitrous individuals.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Goiter, Nodular; Hashimoto Disease; Health; Hepatocyte Growth Factor; Humans; Interleukin-6; Male; Middle Aged; Young Adult | 2009 |
Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto's thyroiditis*.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Case-Control Studies; Epitope Mapping; Female; Hashimoto Disease; Health; Humans; Iodide Peroxidase; Middle Aged; Young Adult | 2008 |